{"changes":[],"country":"NL","description":"Leyden Labs develops nasal sprays delivering antibodies to the respiratory mucosa to block flu, coronaviruses, and other viruses at entry. It targets at-risk groups, including the immunocompromised, and pandemic readiness. Its edge is its Mucosal Protection Platform, where low-dose intranasal antibodies stay effective as viruses mutate.","domain":"leyden-labs.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":"unknown","githubStars":null,"industry":"bio","investors":[],"lat":52.159475,"lng":4.490884,"location":"Leiden","name":"Leyden Labs","rounds":[{"amountQuarantined":false,"amountUsd":73440000,"currency":"EUR","date":"2025-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-25","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"leyden-labs-com","sources":[{"fact":"round","publisher":"sifted","retrievedAt":"2026-05-25","status":"attributed","url":null},{"fact":"existence","publisher":"leyden-labs.com","retrievedAt":"2026-05-25","status":"self-reported","url":"https://leyden-labs.com"},{"fact":"description","publisher":"leyden-labs.com","retrievedAt":"2026-05-25","status":"self-reported","url":"https://leyden-labs.com"}],"stage":"series-b+","techStack":["unknown"],"totalRaisedUsd":73440000,"updatedAt":"2026-05-25"}